Archive for ◊ January, 2014 ◊

• Wednesday, January 29th, 2014

Mountain View, Calif. –January 28, 2014 23andMe, the leading personal genetics company, has participated in the first ever genome-wide association study of the combined asthma-with-hay fever phenotype. Led by researchers at the QIMR Berghofer Medical Research Institute, the study identified 11 independent genetic markers associated with the development of asthma-with-hay fever, including two associations reaching […]

• Wednesday, January 29th, 2014

Negative Pressure Wound Therapy helps reduce infections and other surgical complications, according to a clinical review published by a Smith & Nephew-funded expert panel. Smith & Nephew (FTSE:SN, NYSE:SNN) touted the outcomes of a clinical study review, reporting that Negative Pressure Wound Therapy proved effective in reducing complications when applied to surgical wounds for a few […]

• Wednesday, January 29th, 2014

Hospital equipment maker Hill-Rom (Batesville, IN) plans on cutting approximately 350 workers, or 5% of its global workforce, to save roughly $30 million annually. The restructuring efforts include a downsizing of the firm’s European manufacturing capacity and the closure of one facility there. In addition, Hill-Rom will streamline operations in both the continent and the […]

• Tuesday, January 28th, 2014

St. Jude Medical Announces Organizational and Executive Leadership Changes ST. PAUL, Minn.–(BUSINESS WIRE)– St. Jude Medical, Inc. (STJ), a global medical device company, today announced organizational and leadership changes designed to improve growth. The company will integrate its two operating divisions into one integrated research and development organization, and will combine manufacturing and supply chain […]

• Friday, January 24th, 2014

Johnson & Johnson subsidiary Codman Neuro’s recall of its Trufill n-BCA liquid embolic system gets labeled as a Class I measure by the FDA. Codman Neuro, a division of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes, said the FDA labeled its Trufill n-BCA liquid embolic system recall as Class I, the federal watchdog agency’s highest-risk classification. The […]

• Friday, January 24th, 2014

Google’s clandestine ‘[X]’ laboratory offers new details on its glucose-sensing contact lens project, saying that it’s looking for “expert partners” to help get the technology to market. Google (NSDQ:GOOG) is hoping to forge some new partnerships to support its newly unveiled smart contact lens, which is laden with sensors and transmitters that aim to help diabetics monitor […]

• Thursday, January 23rd, 2014

Jan 21 (Reuters) – Healthcare company Johnson & Johnson cautioned Tuesday that prescription-drug sales would likely lose some momentum this year and forecast 2014 earnings at the lower end of Wall Street expectations, sending its shares down almost 2 percent. Chief Financial Officer Dominic Caruso cautioned that the growth rate of prescription drug sales will “decelerate” this […]

• Wednesday, January 22nd, 2014

P-Cure signed a development deal with Philips Healthcare to advance its proton therapy using Philips imaging technology. Philips (NYSE:PHG) aligned itself with Israel-based medical device company P-Cure, in order to advance the smaller firm’s proton therapy technology. P-Cure develops low-cost proton therapy systems, which are smaller, cheaper radiation therapy system for targeting cancerous tumors. Founded in […]

• Wednesday, January 22nd, 2014

Greatbatch files for European CE Mark for its spinal cord stimulation system, hoping to land marketing approval the treatment of chronic pain of the trunk and limbs. Greatbatch (NYSE:GB) filed a CE Mark application for its spinal cord stimulation system with German notified body TÜV SÜD America. The spinal cord stimulation system comes from Greatbatch’s subsidiary, […]

• Wednesday, January 22nd, 2014

Zynex CEO Thomas Sandgaard downsizes the company’s board of directors as part of a larger strategy to restructure the company. Zynex (OTC:ZYXI) CEO Thomas Sandgaard has cleared the path to reshape the company after cutting its board in half. Sandgaard asked for the resignations of board members Mats Wahlstrom, Mary Beth Vitale, Kevin Smith and Taylor […]